IndraLab

Statements


P5091 inhibits HCT166. 1 / 1
| 1

reach
"P5091 inhibited HCT166 proliferation [86] , whereas P22077 downregulated the USP7 targets MDM2, claspin, and Checkpoint kinase 1 (Chk1) and inhibited neuroblastoma growth [75] ."